🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to evaluate the efficacy and safety of elacestrant, in partic...
Status
Recruiting
Location
Dana Farber Cancer Institute
Start Date
2026-03-25
Trial ID
NCT07467772
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and preli...
Status
Completed
Location
Radius Pharmaceuticals, Inc.
Start Date
2015-01
Trial ID
NCT02338349
Treatments Being Tested
This is an international, multisite, open-label, Phase 1b/2 study, to confi...
Status
Completed
Location
Site 38 - Northwestern University, Feinberg School of Medicine, Northwestern University
Start Date
2023-10-09
Trial ID
NCT05963997
Treatments Being Tested
This Phase 3 clinical study compares the efficacy and safety of elacestrant...
Status
Completed
Location
The University of Arizona Cancer Center
Start Date
2019-05-10
Trial ID
NCT03778931
Treatments Being Tested
The purpose of this study is to visualize and quantify ER-binding sites dur...
Status
Completed
Location
Institut Jules Bordet
Start Date
2016-04-01
Trial ID
NCT02650817
Treatments Being Tested
The purpose of this study is to determine whether RAD1901 is effective in d...
Status
Completed
Location
Radius Health, Inc.
Start Date
2009-03
Trial ID
NCT00875420
This is a Phase 1, multi-center, open-label, non-randomized, parallel group...
Status
Completed
Location
Inland Empire Clinical Trials, LLC
Start Date
2023-03-13
Trial ID
NCT06126575
Treatments Being Tested
This is a multi-site, global, open-label study that includes a phase 1b eva...
Status
Recruiting
Location
Providence Medical Foundation
Start Date
2022-08-31
Trial ID
NCT05386108
Treatments Being Tested
The primary objective of this study was to determine the clinical safety of...
Status
Terminated
Location
Women's Health Care Specialists P.C. - Beyer Research
Start Date
2015-12
Trial ID
NCT02653417
The goal of this research study is to compare a combination of two drugs, c...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2026-01-16
Trial ID
NCT07222215
Treatments Being Tested